News Choose Language View All Languages English Press Releases Spanish Press Releases Sort by Year All Years 2023 (16) 2022 (29) 2021 (17) 2020 (19) 2019 (12) 2018 (18) 2017 (19) 2016 (32) 2015 (43) 2014 (50) 2013 (32) 2012 (17) Search September 28, 2023 Theriva Biologics to Participate in the Emerging Growth Conference August 8, 2023 Theriva™ Biologics Reports Second Quarter 2023 Operational Highlights and Financial Results August 2, 2023 Theriva™ Biologics Announces Key Progress in VIRAGE, an Ongoing, Multinational Phase 2b Trial of VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma August 1, 2023 Theriva™ Biologics to Host Conference Call and Webcast to Discuss Second Quarter 2023 Operational Highlights and Financial Results June 27, 2023 Theriva™ Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Pancreatic Cancer May 23, 2023 Theriva™ Biologics Announces Appointment of Ramon Alemany, Ph.D., to Senior Vice President of Discovery May 11, 2023 Theriva™ Biologics Reports First Quarter 2023 Operational Highlights and Financial Results May 4, 2023 Theriva™ Biologics to Host Conference Call and Webcast to Discuss First Quarter 2023 Operational Highlights and Financial Results April 13, 2023 Theriva™ Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients March 30, 2023 Theriva™ Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
